|
|
|
|
Vol. 54, Issue 5, 889-898, November 1998
Department of Integrative Biology and Pharmacology, University of
Texas Medical School, Houston, Texas 77225
The mechanisms regulating receptor internalization are not well
understood and vary among different G protein-coupled receptors. The
bombesin (Bn)/gastrin-releasing peptide receptor GRP-R, which is
coupled to phospholipase C via the Gq family of transducing proteins, is internalized rapidly after Bn binding. Agonist stimulation leads to rapid receptor phosphorylation, as does activation of protein
kinase C (PKC) by phorbol-12-myristate-13-acetate (PMA). However,
agonist- and PMA-induced phosphorylation occur at different receptor
sites. Here, we examined the role of PKC in GRP-R internalization after
agonist and antagonist binding. We synthesized
[D-Tyr6]Bn(6-13)propylamide
([D-Tyr6]Bn(6-13)PA) and found that it
potently inhibited Bn-stimulated insulin release and
[125I-Tyr4]Bn binding
(Ki = 4.72 nM)
in the HIT-T15 pancreatic cell line. The radiolabeled antagonist
peptide,
[125I-D-Tyr6]Bn(6-13)PA,
bound with high affinity (KD = 0.29 nM at 4°) to a single class of receptor sites,
and competition binding studies exhibited the analog specificity
expected for the GRP-R subtype. Although the agonist
[125I-Tyr4]Bn was internalized rapidly at
37° and subsequently degraded, [125I-D-Tyr6]Bn(6-13)PA was
not internalized and was released into the medium mainly as intact
peptide. The lysosomal inhibitor chloroquine (200 µM) increased the intracellular accumulation of
[125I-Tyr4]Bn but had no effect on the
subcellular distribution of
[125I-D-Tyr6]Bn(6-13)PA.
Consistent with these observations, the treatment of cells with 100 nM Bn at 37° reduced cell surface receptors within
minutes, whereas [D-Tyr6]Bn(6-13)PA had
no effect. The addition of PMA did not induce the internalization of
antagonist-occupied receptors, but pharmacological inhibition of PKC
decreased the rate of agonist-induced receptor internalization. These
results therefore demonstrate that although PKC contributes to
agonist-induced internalization of the GRP-R, it does not elicit
receptor internalization of the antagonist-occupied receptor.
This article has been cited by other articles:
![]() |
R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Moody, S. A. Mantey, T. K. Pradhan, M. Schumann, T. Nakagawa, A. Martinez, J. Fuselier, D. H. Coy, and R. T. Jensen Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells J. Biol. Chem., May 28, 2004; 279(22): 23580 - 23589. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, S. Y. Choi, M. K. Cho, C. H. Lee, and S. G. Kim Thrombin Induces Nitric-oxide Synthase via Galpha 12/13-coupled Protein Kinase C-dependent I-kappa Balpha Phosphorylation and JNK-mediated I-kappa Balpha Degradation J. Biol. Chem., May 2, 2003; 278(19): 17368 - 17378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Hanyaloglu, M. Vrecl, K. M. Kroeger, L. E. C. Miles, H. Qian, W. G. Thomas, and K. A. Eidne Casein Kinase II Sites in the Intracellular C-terminal Domain of the Thyrotropin-releasing Hormone Receptor and Chimeric Gonadotropin-releasing Hormone Receptors Contribute to beta -Arrestin-dependent Internalization J. Biol. Chem., May 18, 2001; 276(21): 18066 - 18074. [Abstract] [Full Text] [PDF] |
||||